Cyclacel Pharmaceuticals SG&A Expense (Quarterly) Trends

Cyclacel Pharmaceuticals Inc (CYCC)

2.345 +0.24 (+11.14%) USD | NASDAQ | May 08, 15:19

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2003. Upgrade now.

Date	Value
December 31, 2023	1.873M
September 30, 2023	1.625M
June 30, 2023	1.575M
March 31, 2023	1.645M
December 31, 2022	2.143M
September 30, 2022	2.054M
June 30, 2022	1.58M
March 31, 2022	1.605M
December 31, 2021	1.941M
September 30, 2021	1.781M
June 30, 2021	1.999M
March 31, 2021	1.739M
December 31, 2020	1.753M
September 30, 2020	1.497M
June 30, 2020	1.309M
March 31, 2020	1.318M
December 31, 2019	1.363M
September 30, 2019	1.285M
June 30, 2019	1.184M
March 31, 2019	1.192M
December 31, 2018	1.473M
September 30, 2018	1.25M
June 30, 2018	1.283M
March 31, 2018	1.364M
December 31, 2017	1.452M

Date	Value
September 30, 2017	1.154M
June 30, 2017	1.267M
March 31, 2017	1.381M
December 31, 2016	1.514M
September 30, 2016	1.273M
June 30, 2016	1.345M
March 31, 2016	1.384M
December 31, 2015	1.726M
September 30, 2015	1.205M
June 30, 2015	1.333M
March 31, 2015	1.468M
December 31, 2014	1.613M
September 30, 2014	1.433M
June 30, 2014	1.386M
March 31, 2014	1.462M
December 31, 2013	1.782M
September 30, 2013	1.529M
June 30, 2013	1.787M
March 31, 2013	2.683M
December 31, 2012	2.663M
September 30, 2012	2.028M
June 30, 2012	2.121M
March 31, 2012	1.768M
December 31, 2011	1.406M
September 30, 2011	1.814M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.184M

Minimum

Jun 2019

2.143M

Maximum

Dec 2022

1.646M

Average

1.625M

Median

Sep 2023

SG&A Expense (Quarterly) Benchmarks